Related Experiment Videos
Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management
A E Pontiroli1, A Calderara, G Pozza
1Istituto Scientifico San Raffaele, Università degli Studi di Milano, Italy.
Diabetes/Metabolism Reviews
|April 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis.
Journal of endocrinological investigation·2023
Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.
International journal of obesity (2005)·2017
Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies.
Obesity reviews : an official journal of the International Association for the Study of Obesity·2017
Bariatric surgery versus medications in the treatment of type 2 diabetes.
Minerva endocrinologica·2015
Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2015
Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.
Diabetes, obesity & metabolism·2014
Islet transplantation: present and future perspectives.
Diabetes/metabolism reviews·1999
MHC restriction to T-cell autoaggression: an emerging understanding of IDDM pathogenesis.
Diabetes/metabolism reviews·1999
Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.
Diabetes/metabolism reviews·1999
Follicular lymphoma and the microenvironment: potential targets and biomarkers.
Expert review of clinical immunology·2026
Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.
Molecular cancer therapeutics·2026
Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.
Cancer reports (Hoboken, N.J.)·2026